Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin

por Nai-Jia Huang, Novalia Pishesha, Jean Mukherjee, Sicai Zhang, Rhogerry Deshycka, Valentino Sudaryo, Min Dong, Charles B. Shoemaker, Harvey F. Lodish
Publicado 2017

A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding

por Guorui Yao, Kwok-ho Lam, Jasmin Weisemann, Lisheng Peng, Nadja Krez, Kay Perry, Charles B. Shoemaker, Min Dong, Andreas Rummel, Rongsheng Jin
Publicado 2017